当前位置: 首页 >> 检索结果
141. Sex-related differences in profiles and clinical outcomes of Inflammatory bowel disease: a systematic review and meta-analysis.
作者: Dana A Salem.;Rawan El-Ijla.;Razan R AbuMusameh.;Khaled A Zakout.;Alaa Y Abu Halima.;Mohammed T Abudiab.;Yahya M Banat.;Basel F Alqeeq.;Mohammed Al-Tawil.;Khaled Matar.
来源: BMC Gastroenterol. 2024年24卷1期425页
Inflammatory bowel disease (IBD) is a chronic and idiopathic condition that includes both Crohn's disease (CD) and ulcerative colitis (UC). The impact of sex on the disease course and the clinical outcomes not fully understood. Our systematic review and meta-analysis aims to explore the differences in the clinical outcomes in IBD.
142. Efficacy and safety of Nivolumab in advanced gastric and gastroesophageal junction cancer: a meta-analysis of randomized controlled trials.
作者: Xinming Lei.;Weimin Huo.;Tian Xu.;Jianguang Xu.;Maoning Liu.;Chengjiang Liu.;Zhangyuan Gu.
来源: BMC Gastroenterol. 2024年24卷1期422页
*CoNivolumab, an immune checkpoint inhibitor, has shown promise in treating advanced unresectable gastric and gastroesophageal junction cancer. This meta-analysis aims to evaluate the efficacy and safety of Nivolumab, alone and in combination with chemotherapy, in this patient population.
143. Long-term outcomes of additional surgery versus surveillance-only clinical decision for early colorectal cancer patients after non-curative endoscopic resection: a meta-analysis.
The clinical decision-making regarding post hoc management of early colorectal cancer (CRC) patients who have undergone non-curative endoscopic resection (ER) remains a subject of debate. This systematic review and meta-analysis aims to compare the clinical outcomes between patients undergoing additional surgery and those receiving surveillance only.
144. Impact of perioperative immunonutrition on postoperative outcomes in pancreaticoduodenectomy: a systematic review and meta-analysis of randomized controlled trials.
作者: Gaofeng Zhang.;Bing Zhao.;Tengang Deng.;Xiaofei He.;Yongpin Chen.;Changtao Zhong.;Jie Chen.
来源: BMC Gastroenterol. 2024年24卷1期412页
This systematic review and meta-analysis aimed to evaluate the impact of perioperative immunonutrition on postoperative outcomes in patients undergoing pancreaticoduodenectomy (PD).
145. Advantages comparison of peritoneal drainage versus no drainage after laparoscopic appendectomy for complicated appendicitis: a meta-analysis.
作者: Hongsheng Wu.;Biling Liao.;Tiansheng Cao.;Tengfei Ji.;Yumei Luo.;Jianbin Huang.;Keqiang Ma.
来源: BMC Gastroenterol. 2024年24卷1期411页
Peritoneal drainage (PD) following laparoscopic appendectomy(LA) has long been considered beneficial for appendicitis patients, especially those with complicated appendicitis. However, recent research has raised doubts about the advantages of PD, as it not only fails to reduce postoperative complications but also prolongs the operative duration and hospital stay and incurs higher medical expenses. Given this controversy, we conducted a meta-analysis to determine whether drainage is necessary after LA for complicated appendicitis. This meta-analysis had registered in PROSPERO(ID: CRD42023472382).
146. Efficacy and safety of tanshinone IIA in combination with mesalazine in the treatment of ulcerative colitis: a Systematic review and meta-analysis.
作者: Xiao Chen.;Qiujun Zhou.;Bolin Wang.;Dandan Feng.;Ronglin Jiang.;Xi Wang.
来源: BMC Gastroenterol. 2024年24卷1期410页
Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by relapsing inflammation of the colon. Tanshinone IIA, a compound derived from traditional Chinese medicine, has demonstrated anti-inflammatory properties and may enhance treatment outcomes when combined with mesalazine. This study aims to determine the overall response rate of Tanshinone IIA in combination with mesalazine for the treatment of UC.
147. The efficacy of CT-P13, a biosimilar of infliximab, in inflammatory bowel diseases: a systematic review and meta-analysis.
作者: Xinyue Hu.;Xiaowei Tang.;Limin Li.;Lian Luo.;Xinsen He.;Qin Yan.;Xiaolin Zhong.
来源: BMC Gastroenterol. 2024年24卷1期406页
Since 2015, an infliximab biosimilar, CT-P13, has been approved for commercial use in many countries, easing the economic burden borne by society and patients. Many clinical trials investigating CT-P13 for the treatment of IBD have been conducted and reported that it may be a substitute for infliximab. However, the differences between the efficacy of CT-P13 and infliximab-originator require further elucidation.
148. Safety comparison of single-donor and pooled fecal microbiota transfer product preparation in ulcerative colitis: systematic review and meta-analysis.
作者: Bastien Laperrousaz.;Benoît Levast.;Mathieu Fontaine.;Stéphane Nancey.;Pierre Dechelotte.;Joël Doré.;Philippe Lehert.
来源: BMC Gastroenterol. 2024年24卷1期402页
Multiple studies have evaluated fecal microbiota transfer (FMT) in patients with ulcerative colitis (UC) using single-donor (SDN) and multidonor (MDN) products. Systematic review and meta-analysis were performed to compare the safety of SDN and MDN products.
149. Adverse Events Associated With Endoscopic Retrograde Cholangiopancreatography: Systematic Review and Meta-Analysis.
作者: Kirles Bishay.;Zhao Wu Meng.;Rishad Khan.;Mehul Gupta.;Yibing Ruan.;Marcus Vaska.;Jordan Iannuzzi.;Dylan E O'Sullivan.;Brittany Mah.;Arun C R Partridge.;Amanda M Henderson.;Howard Guo.;Sunil Samnani.;Max DeMarco.;Yuhong Yuan.;B Joseph Elmunzer.;Rajesh N Keswani.;Sachin Wani.;Zachary L Smith.;Ronald J Bridges.;Steven J Heitman.;Robert J Hilsden.;Darren R Brenner.;Grigorios I Leontiadis.;Nauzer Forbes.
来源: Gastroenterology. 2025年168卷3期568-586页
Endoscopic retrograde cholangiopancreatography (ERCP)-related adverse events (AEs) are associated with morbidity, mortality, and health care expenditure. We aimed to assess incidences and comparisons of ERCP AEs.
150. Birth characteristics and risk of colorectal cancer.
作者: Jianwen Chen.;Xu Ren.;Yalan Wang.;Chengjiang Liu.;Simei Shi.;Bo Sun.
来源: BMC Gastroenterol. 2024年24卷1期397页
There is still controversy over the association between newborns with different birth characteristics and colorectal cancer (CRC) in adulthood. We plan to use systematic reviews and meta-analysis to elucidate this relationship.
151. Risk of Clostridioides difficile infection in inflammatory bowel disease patients undergoing vedolizumab treatment: a systematic review and meta-analysis.
作者: Wei Chen.;Yuhang Liu.;Yuelun Zhang.;Hong Zhang.;Chuyan Chen.;Siying Zhu.;Yanhua Zhou.;Haiying Zhao.;Ye Zong.
来源: BMC Gastroenterol. 2024年24卷1期377页
Inflammatory bowel disease (IBD) is a chronic, relapsing condition wherein biologics have improved disease prognosis but introduced elevated infection susceptibility. Vedolizumab (VDZ) demonstrates unique safety advantages; however, a comprehensive systematic comparison regarding the risk of Clostridioides difficile infection (CDI) between vedolizumab and alternative medications remains absent.
152. Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis.
作者: Ashwin N Ananthakrishnan.;M Hassan Murad.;Frank I Scott.;Manasi Agrawal.;John P Haydek.;Berkeley N Limketkai.;Edward V Loftus.;Siddharth Singh.
来源: Gastroenterology. 2024年167卷7期1460-1482页
We performed an updated systematic review and network meta-analysis to inform the 2024 American Gastroenterological Association (AGA) Clinical Guidelines on the management of moderate-to-severe ulcerative colitis (UC).
153. The prevalence of obesity and underweight in celiac patients at the time of diagnosis: a systematic review and meta-analysis.
作者: Farzad Maleki.;Marjan Hosseinpour.;Ali Delpisheh.;Mansour Bahardoust.;Fatemeh Hajizadeh-Sharafabad.;Mohammad Reza Pashaei.
来源: BMC Gastroenterol. 2024年24卷1期357页
This study aimed to estimate the prevalence of obesity, overweight, and underweight in celiac disease (CD) at diagnosis before starting the Gluten-free diet (GFD).
154. Efficacy and safety of direct-acting antiviral regimen for patients with hepatitis C virus genotype 2: a systematic review and meta-analysis.
Direct-acting antivirals (DAAs) show high cure rates in treating chronic hepatitis C virus (HCV). However, the effect of DAAs on patients infected with genotype 2 (GT2) is difficult to determine despite the availability of several DAA regimens.
155. Interventions to Increase Follow-Up of Abnormal Stool-Based Colorectal Cancer Screening Tests in Safety Net Settings: A Systematic Review.
作者: Rachel B Issaka.;Ari Bell-Brown.;Teresa Jewell.;Sara L Jackson.;Bryan J Weiner.
来源: Gastroenterology. 2024年167卷5期826-833.e3页 156. Effect of factor VIII and FVIII/PC ratio on portal vein thrombosis in liver cirrhosis: a systematic review and meta‑analysis.
作者: Zhinian Wu.;Ying Xiao.;Zeqiang Qi.;Tingyu Guo.;Hua Tong.;Yadong Wang.
来源: BMC Gastroenterol. 2024年24卷1期320页
To date, there is an ongoing debate regarding the ability to predict PVT development using markers of FVIII or FVIII/PC ratio. This study presents evidence-based medical findings on the influence of FVIII activity levels and FVIII/PC values in the formation of PVT in cirrhosis.
157. Incidence and risk factors for colorectal cancer in Africa: a systematic review and meta-analysis.
作者: Nkengeh N Tazinkeng.;Ethan F Pearlstein.;Martha Manda-Mapalo.;Ayooluwatomiwa D Adekunle.;Joao Filipe G Monteiro.;Kelsey Sawyer.;Stella-Maris C Egboh.;Kanwal Bains.;Evaristus S Chukwudike.;Mouhand F Mohamed.;Comfort Asante.;Julius Ssempiira.;Akwi W Asombang.
来源: BMC Gastroenterol. 2024年24卷1期303页
Colorectal cancer (CRC) is the second leading cause of cancer-related death worldwide. There is a significant burden of mortality from colorectal cancer in Africa. Due to the heterogeneity of dietary and lifestyle practices throughout Africa, our work sought to define risk factors for the development of CRC in the African continent.
158. Efficacy and safety of endoscopic nasobiliary drainage versus percutaneous transhepatic cholangial drainage in the treatment of advanced hilar cholangiocarcinoma: a systematic review and meta-analysis.
作者: Huiling Zhou.;Chunxia Liu.;Xianhuan Yu.;Mingye Su.;Jingwen Yan.;Xiangde Shi.
来源: BMC Gastroenterol. 2024年24卷1期302页
To evaluate and compare the efficacy and safety of Endoscopic Nasobiliary Drainage (ENBD) and Percutaneous Transhepatic Cholangiography Drainage (PTCD) in patients with advanced Hilar Cholangiocarcinoma (HCCA) through a meta-analysis of clinical studies.
159. Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.
作者: Youwen Pan.;Yafang Yang.;Jiale Wu.;Haiteng Zhou.;Chao Yang.
来源: BMC Gastroenterol. 2024年24卷1期283页
There is a contradiction in the use of microbiota-therapies, including probiotics, prebiotics, and synbiotics, to improve the condition of patients with nonalcoholic fatty liver disease (NAFLD). The aim of this review was to evaluate the effect of microbiota-therapy on liver injury, inflammation, and lipid levels in individuals with NAFLD.
160. Prevalence of autoimmune pancreatitis in pancreatic resection for suspected malignancy: a systematic review and meta-analysis.
作者: Zain A Karamya.;Attila Kovács.;Dóra Illés.;Bálint Czakó.;Alíz Fazekas.;Nelli Farkas.;Péter Hegyi.;László Czakó.
来源: BMC Gastroenterol. 2024年24卷1期278页
Autoimmune pancreatitis (AIP) is a diagnosis-challenging disease that often mimics pancreatic malignancy. Pancreatic resection is considered to be a curative treatment for pancreatic ductal adenocarcinoma (PDAC). This meta-analysis aims to study the incidence of AIP in patients who have undergone pancreatic resection for clinical manifestation of cancer.
|